Skip to main content
Clinical Trials/ITMCTR2000004186
ITMCTR2000004186Recruiting未知

A protocol of randomized controlled trial for Modified Xiaoyao Powder in the treatment of chronic obstructive pulmonary disease combined mild to moderate depression

Hospital of Chengdu University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 65 (—)
Sex
All

Inclusion Criteria

  • •1. Aged 18 to 65 years men and women;
  • •2. Patients who had received a diagnosis of COPD combined mild to moderate depression (HAMD-17 score 7 to 24) and meet the syndrome of stagnation of liver qi of depression;
  • •3. The course of depression does not exceed 3 months;
  • •4. The patients has not taken antidepressants in the past 1 month;
  • •5. Agree to participate and sign an informed consent form.

Exclusion Criteria

  • •1. A history of a suicide attempt treament-resistant depression, and familial mental illness;
  • •2. Had a recent history of other acute or chronic significant clinical manifestations medical conditions;
  • •3. A history of bipolar disorder, schizophrenia, or schizo affective disorder;
  • •4. Patients who cannot actively cooperate with the treatment.

Investigators

Sponsor
Hospital of Chengdu University of Traditional Chinese Medicine

Similar Trials